Artiva Biotherapeutics, Inc. (ARTV) vs Opus Genetics, Inc. (IRD)
A side-by-side comparison of Artiva Biotherapeutics, Inc. and Opus Genetics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARTV
Artiva Biotherapeutics, Inc.
$7.00HealthcareDelayed quote: Oct 6, 2026, 10:39 AM EDT
IRD
Opus Genetics, Inc.
$4.21HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
Total return — ARTV vs IRD
growth of $100 · dividends reinvested · last 2yARTV -52.8% (-31.3%/yr)IRD +239.5% (+84.3%/yr)IRD compounded faster over this window
Log scale — wide-divergence pair
ARTV IRD
ARTV vs IRD: by the numbers
- •IRD is the larger company ($348M vs $342M market cap).
- •Both run net losses; ARTV's is the smaller (0.00% vs -1091.82% net margin).
Metrics side by side
Valuation
| Metric | ARTV | IRD |
|---|---|---|
| P/S ratio | N/A | 35.28 |
| P/B ratio | 0.98 | N/A |
Profitability
| Metric | ARTV | IRD |
|---|---|---|
| Gross margin | 0.00% | 99.87% |
| Operating margin | 0.00% | -271.90% |
| Net margin | 0.00% | -1091.82% |
| ROE | -26.14% | N/A |
| ROIC | -27.16% | -59.29% |
Growth (annualized)
| Metric | ARTV | IRD |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 150.49% |
Go deeper
Dig into the metrics
Artiva Biotherapeutics ROEOpus Genetics ROEArtiva Biotherapeutics operating marginOpus Genetics operating marginArtiva Biotherapeutics revenue growthOpus Genetics revenue growthArtiva Biotherapeutics free cash flowOpus Genetics free cash flow
Artiva Biotherapeutics & Opus Genetics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.